Skip to content
PubMed This is a summary of 82 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 82 referenced papers

Top Authors

Michael Zech
Helmholtz Munich
Kailash P. Bhatia
National Hospital for Neurology and Neurosurgery
Jens Volkmann
Universitätsklinikum Würzburg
Jean‐Pierre Lin
Guy's and St Thomas' NHS Foundation Trust
Elena Moro
Centre Hospitalier Universitaire de Grenoble
Juliane Winkelmann
Helmholtz Munich
Sylvia Boesch
Innsbruck Medical University
Christine Klein
University of Lübeck
Alfonso A. Fasano
University of Toronto
Bettina Balint
Heidelberg University

Top Institutions

Ranked by publications Top 10 institutions
06

Guy's and St Thomas' NHS Foundation Trust

London, United Kingdom

27 papers

References

References (82)
  1. 1

    Isolated and combined dystonia syndromes - an update on new genes and their phenotypes.

    Balint B, Bhatia KP

    European journal of neurology 2015; (22(4)):610-7 doi:10.1111/ene.12650.

    PMID: 25643588
  2. 2

    Short- and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystonia.

    Brüggemann N, Kühn A, Schneider SA, et al.

    Neurology 2015; (84(9)):895-903 doi:10.1212/WNL.0000000000001312.

    PMID: 25653290
  3. 3

    Childhood dystonias.

    Tabbal SD

    Current treatment options in neurology 2015; (17(3)):339 doi:10.1007/s11940-015-0339-4.

    PMID: 25704239
  4. 4

    Brain Stimulation for Torsion Dystonia.

    Fox MD, Alterman RL

    JAMA neurology 2015; (72(6)):713-9 doi:10.1001/jamaneurol.2015.51.

    PMID: 25894231
  5. 5

    Acute colonic pseudo-obstruction in a child taking trihexyphenidyl for drooling: Prescribers beware.

    Begbie F, Walker G, Kubba H, Sabharwal A

    International journal of pediatric otorhinolaryngology 2015; (79(6)):932-934 doi:10.1016/j.ijporl.2015.03.027.

    PMID: 25912627
  6. 6

    Common therapeutic mechanisms of pallidal deep brain stimulation for hypo- and hyperkinetic movement disorders.

    McCairn KW, Iriki A, Isoda M

    Journal of neurophysiology 2015; (114(4)):2090-104 doi:10.1152/jn.00223.2015.

    PMID: 26180116
  7. 7

    Intrathecal baclofen for treating spasticity in children with cerebral palsy.

    Hasnat MJ, Rice JE

    The Cochrane database of systematic reviews 2015; CD004552 doi:10.1002/14651858.CD004552.pub2.

    PMID: 26563961
  8. 8

    Long-term results of deep brain stimulation in a cohort of eight children with isolated dystonia.

    Krause P, Lauritsch K, Lipp A, et al.

    Journal of neurology 2016; (263(11)):2319-2326 doi:10.1007/s00415-016-8253-6.

    PMID: 27567612
  9. 9

    Clinical exome sequencing in early-onset generalized dystonia and large-scale resequencing follow-up.

    Zech M, Boesch S, Jochim A, et al.

    Movement disorders : official journal of the Movement Disorder Society 2017; (32(4)):549-559 doi:10.1002/mds.26808.

    PMID: 27666935
  10. 10

    Tor1a+/- mice develop dystonia-like movements via a striatal dopaminergic dysregulation triggered by peripheral nerve injury.

    Ip CW, Isaias IU, Kusche-Tekin BB, et al.

    Acta neuropathologica communications 2016; (4(1)):108 doi:10.1186/s40478-016-0375-7.

    PMID: 27716431
  11. 11

    Haploinsufficiency of KMT2B, Encoding the Lysine-Specific Histone Methyltransferase 2B, Results in Early-Onset Generalized Dystonia.

    Zech M, Boesch S, Maier EM, et al.

    American journal of human genetics 2016; (99(6)):1377-1387 doi:10.1016/j.ajhg.2016.10.010.

    PMID: 27839873
  12. 12

    Efficacy of pallidal stimulation in isolated dystonia: a systematic review and meta-analysis.

    Moro E, LeReun C, Krauss JK, et al.

    European journal of neurology 2017; (24(4)):552-560 doi:10.1111/ene.13255.

    PMID: 28186378
  13. 13

    l-Dopa in dystonia: A modern perspective.

    Maas RPPWM, Wassenberg T, Lin JP, et al.

    Neurology 2017; (88(19)):1865-1871 doi:10.1212/WNL.0000000000003897.

    PMID: 28389587
  14. 14

    Clinical Management of Dystonia in Childhood.

    Luc QN, Querubin J

    Paediatric drugs 2017; (19(5)):447-461 doi:10.1007/s40272-017-0243-3.

    PMID: 28620849
  15. 15

    Safety and efficacy of high-dose enteral, intravenous, and transdermal clonidine for the acute management of severe intractable childhood dystonia and status dystonicus: An illustrative case-series.

    Nakou V, Williamson K, Arichi T, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2017; (21(6)):823-832 doi:10.1016/j.ejpn.2017.07.007.

    PMID: 28844551
  16. 16

    Cognition in childhood dystonia: a systematic review.

    Coenen MA, Eggink H, Tijssen MA, Spikman JM

    Developmental medicine and child neurology 2018; (60(3)):244-255 doi:10.1111/dmcn.13632.

    PMID: 29238959
  17. 17

    Mutant torsinA in the heterozygous DYT1 state compromises HSV propagation in infected neurons and fibroblasts.

    György B, Cruz L, Yellen D, et al.

    Scientific reports 2018; (8(1)):2324 doi:10.1038/s41598-018-19865-2.

    PMID: 29396398
  18. 18

    Basic and Translational Neuroscience of Childhood-Onset Dystonia: A Control-Theory Perspective.

    Sanger TD

    Annual review of neuroscience 2018; (41()):41-59 doi:10.1146/annurev-neuro-080317-061504.

    PMID: 29490197
  19. 19

    Surgical treatment of dystonia.

    Cury RG, Kalia SK, Shah BB, et al.

    Expert review of neurotherapeutics 2018; (18(6)):477-492 doi:10.1080/14737175.2018.1478288.

    PMID: 29781334
  20. 20

    Resting-State Pallidal-Cortical Oscillatory Couplings in Patients With Predominant Phasic and Tonic Dystonia.

    Yokochi F, Kato K, Iwamuro H, et al.

    Frontiers in neurology 2018; (9()):375 doi:10.3389/fneur.2018.00375.

    PMID: 29904367
  21. 21

    Dystonia: diagnosis and management.

    Albanese A, Di Giovanni M, Lalli S

    European journal of neurology 2019; (26(1)):5-17 doi:10.1111/ene.13762.

    PMID: 30035844
  22. 22

    Motor and non-motor determinants of health-related quality of life in young dystonia patients.

    Eggink H, Coenen MA, de Jong R, et al.

    Parkinsonism & related disorders 2019; (58()):50-55 doi:10.1016/j.parkreldis.2018.08.008.

    PMID: 30181088
  23. 23

    Dystonia.

    Balint B, Mencacci NE, Valente EM, et al.

    Nature reviews. Disease primers 2018; (4(1)):25 doi:10.1038/s41572-018-0023-6.

    PMID: 30237473
  24. 24

    Deep brain stimulation for pediatric dystonia: a meta-analysis with individual participant data.

    Elkaim LM, Alotaibi NM, Sigal A, et al.

    Developmental medicine and child neurology 2019; (61(1)):49-56 doi:10.1111/dmcn.14063.

    PMID: 30320439
  25. 25

    Deep Brain Stimulation for the Dystonias: Evidence, Knowledge Gaps, and Practical Considerations.

    Reese R, Volkmann J

    Movement disorders clinical practice 2017; (4(4)):486-494 doi:10.1002/mdc3.12519.

    PMID: 30363085
  26. 26

    Nonmotor Symptoms in Dopa-Responsive Dystonia.

    Antelmi E, Stamelou M, Liguori R, Bhatia KP

    Movement disorders clinical practice 2015; (2(4)):347-356 doi:10.1002/mdc3.12211.

    PMID: 30363518
  27. 27

    SPG11 Mutations Associated With a Complex Phenotype Resembling Dopa-Responsive Dystonia.

    Wijemanne S, Shulman JM, Jimenez-Shahed J, et al.

    Movement disorders clinical practice 2015; (2(2)):149-154 doi:10.1002/mdc3.12144.

    PMID: 30363882
  28. 28

    Twelve-year Follow-up of A Large Italian Family with Atypical Phenotypes of DYT1-dystonia.

    Magrinelli F, Bacchin R, Tinazzi M, Gambarin M

    Movement disorders clinical practice 2019; (6(2)):166-170 doi:10.1002/mdc3.12712.

    PMID: 30838317
  29. 29

    Pharmacological management of abnormal tone and movement in cerebral palsy.

    Lumsden DE, Crowe B, Basu A, et al.

    Archives of disease in childhood 2019; (104(8)):775-780 doi:10.1136/archdischild-2018-316309.

    PMID: 30948360
  30. 30

    Outcomes of Intrathecal Baclofen Therapy Compared With Deep Brain Stimulation in a Patient With Dystonic Cerebral Palsy: A Case Report.

    Chae M, Hong S, Jung NY, et al.

    Annals of rehabilitation medicine 2019; (43(3)):335-340 doi:10.5535/arm.2019.43.3.335.

    PMID: 31311256
  31. 31

    ADCY5-Related Dyskinesia: Improving Clinical Detection of an Evolving Disorder.

    Vijiaratnam N, Bhatia KP, Lang AE, et al.

    Movement disorders clinical practice 2019; (6(7)):512-520 doi:10.1002/mdc3.12816.

    PMID: 31538084
  32. 32

    Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice.

    Yokoi F, Oleas J, Xing H, et al.

    Neurobiology of disease 2020; (134()):104638 doi:10.1016/j.nbd.2019.104638.

    PMID: 31618684
  33. 33

    Clinical diagnostic exome sequencing in dystonia: Genetic testing challenges for complex conditions.

    Powis Z, Towne MC, Hagman KDF, et al.

    Clinical genetics 2020; (97(2)):305-311 doi:10.1111/cge.13657.

    PMID: 31628766
  34. 34

    Update on KMT2B-Related Dystonia.

    Zech M, Lam DD, Winkelmann J

    Current neurology and neuroscience reports 2019; (19(11)):92 doi:10.1007/s11910-019-1007-y.

    PMID: 31768667
  35. 35

    Caregiver burden and health-related quality of life in idiopathic dystonia patients under botulinum toxin treatment: a cross-sectional study.

    Drexel SC, Klietz M, Kollewe K, et al.

    Journal of neural transmission (Vienna, Austria : 1996) 2020; (127(1)):61-70 doi:10.1007/s00702-019-02109-6.

    PMID: 31802240
  36. 36

    Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysis.

    Artusi CA, Dwivedi A, Romagnolo A, et al.

    Journal of neurology, neurosurgery, and psychiatry 2020; (91(4)):426-433 doi:10.1136/jnnp-2019-322169.

    PMID: 32079672
  37. 37

    Clinical and Genetic Heterogeneity in a Cohort of Chinese Children With Dopa-Responsive Dystonia.

    Chen Y, Bao X, Wen Y, et al.

    Frontiers in pediatrics 2020; (8()):83 doi:10.3389/fped.2020.00083.

    PMID: 32185155
  38. 38

    Failure to thrive - an overlooked manifestation of KMT2B-related dystonia: a case presentation.

    Ng A, Galosi S, Salz L, et al.

    BMC neurology 2020; (20(1)):246 doi:10.1186/s12883-020-01798-x.

    PMID: 32546208
  39. 39

    Clinical phenotypes, genotypes and treatment in Chinese dystonia patients with KMT2B variants.

    Li XY, Dai LF, Wan XH, et al.

    Parkinsonism & related disorders 2020; (77()):76-82 doi:10.1016/j.parkreldis.2020.06.002.

    PMID: 32634684
  40. 40

    Dopa-responsive dystonia caused by tyrosine hydroxylase deficiency: Three cases report and literature review.

    Dong HY, Feng JY, Yue XJ, et al.

    Medicine 2020; (99(33)):e21753 doi:10.1097/MD.0000000000021753.

    PMID: 32872068
  41. 41

    Fifteen-minute consultation: Approach to investigation and management of childhood dystonia.

    Forman EB, King MD, Gorman KM

    Archives of disease in childhood. Education and practice edition 2021; (106(2)):71-77 doi:10.1136/archdischild-2019-318131.

    PMID: 32928841
  42. 42

    Clinical characteristics of ataxia-telangiectasia presenting dystonia as a main manifestation.

    Kim M, Kim AR, Park J, et al.

    Clinical neurology and neurosurgery 2020; (199()):106267 doi:10.1016/j.clineuro.2020.106267.

    PMID: 33080427
  43. 43

    Monogenic variants in dystonia: an exome-wide sequencing study.

    Zech M, Jech R, Boesch S, et al.

    The Lancet. Neurology 2020; (19(11)):908-918 doi:10.1016/S1474-4422(20)30312-4.

    PMID: 33098801
  44. 44

    Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies.

    Esquenazi A, Delgado MR, Hauser RA, et al.

    Frontiers in neurology 2020; (11()):576117 doi:10.3389/fneur.2020.576117.

    PMID: 33101184
  45. 45

    Isolated dystonia: clinical and genetic updates.

    Domingo A, Yadav R, Ozelius LJ

    Journal of neural transmission (Vienna, Austria : 1996) 2021; (128(4)):405-416 doi:10.1007/s00702-020-02268-x.

    PMID: 33247415
  46. 46

    Dystonia updates: definition, nomenclature, clinical classification, and etiology.

    Grütz K, Klein C

    Journal of neural transmission (Vienna, Austria : 1996) 2021; (128(4)):395-404 doi:10.1007/s00702-021-02314-2.

    PMID: 33604773
  47. 47

    Early-onset autosomal dominant GTP-cyclohydrolase I deficiency: Diagnostic delay and residual motor signs.

    Kim W, Cho JS, Shim YK, et al.

    Brain & development 2021; (43(7)):759-767 doi:10.1016/j.braindev.2021.02.006.

    PMID: 33875303
  48. 48

    Deep Brain Stimulation in KMT2B-Related Dystonia: Case Report and Review of the Literature With Special Emphasis on Dysarthria and Speech.

    Abel M, Pfister R, Hussein I, et al.

    Frontiers in neurology 2021; (12()):662910 doi:10.3389/fneur.2021.662910.

    PMID: 34054706
  49. 49

    Pallidal and Cortical Oscillations in Freely Moving Patients With Dystonia.

    Averna A, Arlotti M, Rosa M, et al.

    Neuromodulation : journal of the International Neuromodulation Society 2023; (26(8)):1661-1667 doi:10.1111/ner.13503.

    PMID: 34328685
  50. 50

    Relationship of Genotype, Phenotype, and Treatment in Dopa-Responsive Dystonia: MDSGene Review.

    Weissbach A, Pauly MG, Herzog R, et al.

    Movement disorders : official journal of the Movement Disorder Society 2022; (37(2)):237-252 doi:10.1002/mds.28874.

    PMID: 34908184
  51. 51

    Recognizing Atypical Dopa-Responsive Dystonia and Its Mimics.

    Salles PA, Terán-Jimenez M, Vidal-Santoro A, et al.

    Neurology. Clinical practice 2021; (11(6)):e876-e884 doi:10.1212/CPJ.0000000000001125.

    PMID: 34992971
  52. 52

    GPi-DBS for KMT2B-Associated Dystonia: Systematic Review and Meta-Analysis.

    Rajan R, Garg K, Saini A, et al.

    Movement disorders clinical practice 2022; (9(1)):31-37 doi:10.1002/mdc3.13374.

    PMID: 35005062
  53. 53

    Possible EIF2AK2-Associated Stress-Related Neurological Decompensation with Combined Dystonia and Striatal Lesions.

    Waller SE, Morales-Briceño H, Williams L, et al.

    Movement disorders clinical practice 2022; (9(2)):240-244 doi:10.1002/mdc3.13384.

    PMID: 35146062
  54. 54

    Utility of Clinical Exome Sequencing in Dystonia: A Single-Center Study From India.

    Holla VV, Neeraja K, Stezin A, et al.

    Journal of movement disorders 2022; (15(2)):156-161 doi:10.14802/jmd.21146.

    PMID: 35287262
  55. 55

    Deep Brain Stimulation for Pediatric Dystonia: A Review of the Literature and Suggested Programming Algorithm.

    Gelineau-Morel R, Kruer MC, Garris JF, et al.

    Journal of child neurology 2022; (37(10-11)):813-824 doi:10.1177/08830738221115248.

    PMID: 36053123
  56. 56

    Restoration of functional network state towards more physiological condition as the correlate of clinical effects of pallidal deep brain stimulation in dystonia.

    Filip P, Jech R, Fečíková A, et al.

    Brain stimulation 2022; (15(5)):1269-1278 doi:10.1016/j.brs.2022.08.025.

    PMID: 36096443
  57. 57

    Early-onset generalized dystonia caused by a new mutation in the KMT2B gene: Case report

    Rangel YA, Espinosa E

    Biomedica : revista del Instituto Nacional de Salud 2022; (42(3)):429-434 doi:10.7705/biomedica.6296.

    PMID: 36122281
  58. 58

    Elective and Emergency Deep Brain Stimulation in Refractory Pediatric Monogenetic Movement Disorders Presenting with Dystonia: Current Practice Illustrated by Two Cases.

    Garofalo M, Beudel M, Dijk JM, et al.

    Neuropediatrics 2023; (54(1)):44-52 doi:10.1055/a-1959-9088.

    PMID: 36223877
  59. 59

    Deep brain stimulation in animal models of dystonia.

    Perl S, Lüttig A, Köhling R, Richter A

    Neurobiology of disease 2022; (175()):105912 doi:10.1016/j.nbd.2022.105912.

    PMID: 36307031
  60. 60

    Trihexyphenidyl in young children with dystonic cerebral palsy: A single arm study.

    Rajkumar L, Ventatakrishnan A, Sairam S, et al.

    Journal of pediatric rehabilitation medicine 2023; (16(1)):115-124 doi:10.3233/PRM-210087.

    PMID: 36373299
  61. 61

    Peripheral nerve injury elicits microstructural and neurochemical changes in the striatum and substantia nigra of a DYT-TOR1A mouse model with dystonia-like movements.

    Rauschenberger L, Krenig EM, Stengl A, et al.

    Neurobiology of disease 2023; (179()):106056 doi:10.1016/j.nbd.2023.106056.

    PMID: 36863527
  62. 62

    Dystonias: Clinical Recognition and the Role of Additional Diagnostic Testing.

    Stephen CD, Dy-Hollins M, Gusmao CM, et al.

    Seminars in neurology 2023; (43(1)):17-34 doi:10.1055/s-0043-1764292.

    PMID: 36972613
  63. 63

    Early-onset inherited dystonias versus late-onset idiopathic dystonias: Same or different biological mechanisms?

    Erro R, Monfrini E, Di Fonzo A

    International review of neurobiology 2023; (169()):329-346 doi:10.1016/bs.irn.2023.05.002.

    PMID: 37482397
  64. 64

    DYT-TOR1A dystonia: an update on pathogenesis and treatment.

    Fan Y, Si Z, Wang L, Zhang L

    Frontiers in neuroscience 2023; (17()):1216929 doi:10.3389/fnins.2023.1216929.

    PMID: 37638318
  65. 65

    Dystonia and Parkinsonism in COA7-related disorders: expanding the phenotypic spectrum.

    Higuchi Y, Ando M, Kojima F, et al.

    Journal of neurology 2024; (271(1)):419-430 doi:10.1007/s00415-023-11998-3.

    PMID: 37750949
  66. 66

    Dystonia Deafness Syndrome: A Rare Deep Brain Stimulation Responsive Dystonia.

    Kola S, Kandadai RM, Kashyap M, et al.

    Annals of Indian Academy of Neurology 2023; (26(5)):766-768 doi:10.4103/aian.aian_319_23.

    PMID: 38022471
  67. 67

    Physician Approaches to the Pharmacologic Treatment of Dystonia in Cerebral Palsy.

    Lott E, Fehlings D, Gelineau-Morel R, et al.

    medRxiv : the preprint server for health sciences 2024; doi:10.1101/2024.02.01.24302121.

    PMID: 38352331
  68. 68

    Dopa-responsive dystonia and paroxysmal dystonic attacks associated with ATP1A3 gene variant.

    Soares MC, Parmera JB, Bezerra MER, Cury RG

    Practical neurology 2024; (24(4)):326-328 doi:10.1136/pn-2023-004045.

    PMID: 38453474
  69. 69

    Long-Term Globus Pallidus Internus Deep Brain Stimulation in Pediatric Non-Degenerative Dystonia: A Cohort Study and a Meta-Analysis.

    Duga V, Giossi R, Romito LM, et al.

    Movement disorders : official journal of the Movement Disorder Society 2024; (39(7)):1131-1144 doi:10.1002/mds.29815.

    PMID: 38646731
  70. 70

    Actigraph-based quantification of sleep in children with dystonia undergoing deep brain stimulation.

    Zhang F, Mithani K, Breitbart S, et al.

    Neurosurgical focus 2024; (56(6)):E17 doi:10.3171/2024.3.FOCUS2462.

    PMID: 38823060
  71. 71

    A Classic Cornelia De Lange Syndrome Type 5 (CdLS5) With a De Novo Missense Variation of p.Gly210Arg in the HDAC8 Gene With a Novel Phenotype of Generalized Dystonia.

    Chhajed M, Lallar M, Gunasekaran PK, et al.

    Cureus 2024; (16(5)):e60838 doi:10.7759/cureus.60838.

    PMID: 38910710
  72. 72

    A Systematic Review of Botulinum Toxin Injection in Pediatric Dystonia.

    Rasera A, Squintani GM, Cerruto MA

    Toxins 2024; (16(7)) doi:10.3390/toxins16070289.

    PMID: 39057929
  73. 73

    The clinical spectrum and pathogenesis associated with KMT2B variants in Chinese pediatric patients.

    Ding S, Xie G, Han Z, et al.

    Parkinsonism & related disorders 2024; (129()):107172 doi:10.1016/j.parkreldis.2024.107172.

    PMID: 39418857
  74. 74

    KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation.

    Cif L, Demailly D, Lin JP, et al.

    ArXiv 2025;.

    PMID: 39990802
  75. 75

    Clinical and Basic Research on Dopa-Responsive Dystonia: Neuropathological and Neurochemical Findings.

    Furukawa Y

    Juntendo medical journal 2025; (71(1)):2-10 doi:10.14789/ejmj.JMJ24-0023-R.

    PMID: 40109402
  76. 76

    Clinical Presentation of KMT2B-Related Dystonia: A Case Report.

    Onoprishvili E, Khelaia L, Bedoshvili A, et al.

    Cureus 2025; (17(3)):e81454 doi:10.7759/cureus.81454.

    PMID: 40303543
  77. 77

    Altered Functional Brain Connectivity in Dyt1 Knock-in mouse models.

    Adury RZ, Wilkes BJ, Girdhar P, et al.

    Dystonia (Lausanne, Switzerland) 2025; (4()) doi:10.3389/dyst.2025.13874.

    PMID: 40735249
  78. 78

    Generalized dystonia unraveled: Molecular mechanisms, diagnostic strategies, and treatment paradigms.

    Yarahmadi F, Shoiebi A, Shariati M, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(11)):5657-5669 doi:10.1007/s10072-025-08404-3.

    PMID: 40841848
  79. 79

    Surgical Complications of Deep Brain Stimulation in Children Across Targets and Indications: Multicenter Analysis of the CHILD-DBS Registry.

    Balachandar A, Verhey LH, Mithani K, et al.

    Neurology 2025; (105(9)):e214201 doi:10.1212/WNL.0000000000214201.

    PMID: 41071966
  80. 80

    KMT2B-related disorders in Austria: clinical features and long-term outcome after deep brain stimulation.

    Indelicato E, Siegert S, Langer A, et al.

    Frontiers in neurology 2026; (17()):1727854 doi:10.3389/fneur.2026.1727854.

    PMID: 41738007
  81. 81

    Clinical, imaging and genetic profile of KMT2B-related dystonia: a review of published cases.

    Mahale RR, Khanda P, Roy S, Mailankody P

    Journal of neural transmission (Vienna, Austria : 1996) 2026; (133(7)):1511-1518 doi:10.1007/s00702-026-03153-9.

    PMID: 41925783
  82. 82

    Acute and Chronic Local Field Potential Recordings in Dystonia-A Systematic Review.

    Horan J, Donlon E, Gill A, et al.

    Movement disorders clinical practice 2026; doi:10.1002/mdc3.70744.

    PMID: 42494087